Oligodendrogliomas (ODs) : diagnosis, outcomes and prognosis /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Reeves, Chad (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Science Publishers, Inc., [2016]
Colección:Cancer etiology, diagnosis, and treatments.
Temas:
Oligodendroglia.
Gliomas.
Nervous system > Tumors.
Brain > Tumors.
Oligodendroglia
Glioma
Nervous System Neoplasms
Brain Neoplasms
Oligodendroglie.
Gliome.
Système nerveux > Tumeurs.
Cerveau > Tumeurs.
HEALTH & FITNESS / Diseases / General
MEDICAL / Clinical Medicine
MEDICAL / Diseases
MEDICAL / Evidence-Based Medicine
MEDICAL / Internal Medicine
Brain > Tumors
Gliomas
Nervous system > Tumors
Acceso en línea:Texto completo
Tabla de Contenidos:
  • OLIGODENDROGLIOMAS (ODS) DIAGNOSIS, OUTCOMES AND PROGNOSIS ; OLIGODENDROGLIOMAS (ODS) DIAGNOSIS, OUTCOMES AND PROGNOSIS ; CONTENTS ; PREFACE ; Chapter 1 PATHOLOGY, MOLECULAR MECHANISMS AND CLINICAL REFERENCES OF OLIGODENDROGLIOMAS ; ABSTRACT; 1. INTRODUCTION; 1.1. The Origin of Oligodendroglioma; 1.2. Epidemiology; 1.3. Clinical Features; 1.4. Neuroradiological Features; 2. PATHOLOGY ; 2.1. Macroscopic Appearance ; 2.2. Microscopic Appearance ; OII ; OIII ; OAII ; OAIII; GBMO; 2.3. Microglia/Macrophages ; 2.4. Differential Diagnosis and Prognosis
  • 3. MOLECULAR GENETICS WITH REFERENCE TO DIFFERENTIAL DIAGNOSIS AND PROGNOSIS 3.1. 1p/19q Chromosomal Status ; 3.2. Mechanism of the Combined Loss of Chromosomes 1p and 19q ; 3.3. Methods for the Detection of 1p/19q Chromosomal Status ; 3.4. Candidate Tumor Suppressor Genes (TSGs) on 1p and 19q ; 3.5. IDH1/2 Mutations ; 3.6. Telomerase Reverse Transcriptase (TERT) Promoter Mutations ; 3.7. ATRX Mutations ; 3.8. CIC and FUBP1 Mutations ; 3.9. O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Hypermethylation and G-CIMP ; 3.10. Epithelial Membrane Protein 3 (EMP3)
  • 3.11. Anaplastic Oligodendroglioma 3.12. Pediatric Oligodendroglioma ; 3.13. GBMO ; 3.14. Timing and Relationships with Gliomagenesis ; 4. MICRORNAS (MIRNAS) ; 5. TREATMENT ; 6. PROGNOSIS ; CONCLUSION; ACKNOWLEDGMENT ; REFERENCES ; Chapter 2 MOLECULAR MARKERS OF OLIGODENDROGLIOMAS ; ABSTRACT ; INTRODUCTION ; EPIDEMIOLOGY AND AETIOLOGY ; TUMOUR SIGNS AND SYMPTOMS ; TREATMENT OF OLIGODENDROGLIAL TUMOURS ; HISTOPATHOLOGY AND NEUROONCOLOGY ; THE IMPORTANCE OF MOLECULAR MARKERS ; Chromosomes 1 and 19 and the Prognostic and Diagnostic Value of 1p and 19q Abnormalities ; MGMT Mutation
  • Hypermethylation Mutations in p53Gene ; Growth Factors and Other Genetic Abnormalities ; CONCLUSION; REFERENCES; Chapter 3 OLIGODENDROGLIOMA LOOK-ALIKES: THE HISTOPATHOLOGIC DIFFERENTIAL DIAGNOSIS ; ABSTRACT ; INTRODUCTION ; WHAT DOES OLIGODENDROGLIOMA LOOK LIKE? ; DIFFUSE ASTROCYTOMA VERSUS OLIGODENDROGLIOMA ; OLIGOASTROCYTOMA/MIXED GLIOMA VERSUS OLIGODENDROGLIOMA ; PILOCYTIC ASTROCYTOMA VERSUS OLIGODENDROGLIOMA ; PAPILLARY GLIONEURONAL TUMOR VERSUS OLIGODENDROGLIOMA; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR VERSUS OLIGODENDROGLIOMA ; GANGLIOGLIOMA VERSUS OLIGODENDROGLIOMA
  • CENTRAL NEUROCYTOMA VERSUS OLIGODENDROGLIOMA CLEAR CELL EPENDYMOMA VERSUS OLIGODENDROGLIOMA ; ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE VERSUS OLIGODENDROGLIOMA ; INFLAMMATORY-RELATED LESIONS VERSUS OLIGODENDROGLIOMAS ; CONCLUSION; REFERENCES ; Chapter 4 LESSONS LEARNED FROM AWAKE BRAIN FUNCTION MAPPING IN AGGRESSIVE MULTIMODAL RESECTION OF OLIGODENDROGLIOMAS ; ABSTRACT ; INTRODUCTION; ROLE FOR SURGERY ; ONCOFUNCTIONAL BALANCE ; MAPPING; ANATOMO-FUNCTIONAL VARIABILITY ; PLASTICITY; SELECTED CASES ; ALTERNATIVES TO INTRA-OPERATIVE MAPPING ; SURGICAL ADJUVANTS

Ejemplares similares